trial
as of 2026-07-01Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects
NCTId NCT01289080
at a glance
Phase 1 · Completed
Enrollment 19 (actual)
Primary completion 2011-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1
Status
Completed
Enrollment
19 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2011-01
Primary completion
2011-12
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
Investigators
1
Aleksandar SkubanStudy Director
Sites
2 total
Miami, United StatesMinneapolis, United States
Facts & assertions
4 sourced
Enrollment
19
Phase
PHASE1
Primary Completion Date
2011-12
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
indication
investigator
person